Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 946 AL 960

Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration

Tilley BS, Smith C, Pavese N, Attems J.

BMJ Case Rep. 2019 Mar 7;12(3):e228305. doi: 10.1136/bcr-2018-228305.

The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics

Pajarillo E, Rizor A, Lee J, Aschner M, Lee E.

Neuropharmacology. 2019 Dec 15;161:107559. doi: 10.1016/j.neuropharm.2019.03.002. Epub 2019 Mar 6.

Novel function of VEGF-B as an antioxidant and therapeutic implications

Chen R, Lee C, Lin X, Zhao C, Li X.

Pharmacol Res. 2019 May;143:33-39. doi: 10.1016/j.phrs.2019.03.002. Epub 2019 Mar 6.

Current treatment of behavioral and cognitive symptoms of Parkinson's disease

Rektorova I.

Parkinsonism Relat Disord. 2019 Feb;59:65-73. doi: 10.1016/j.parkreldis.2019.02.042. Epub 2019 Feb 28.

Rhythmic priming across effector systems: A randomized controlled trial with Parkinson's disease patients

Braun Janzen T, Haase M, Thaut MH.

Hum Mov Sci. 2019 Apr;64:355-365. doi: 10.1016/j.humov.2019.03.001. Epub 2019 Mar 7.

α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis

Mehra S, Sahay S, Maji SK.

Biochim Biophys Acta Proteins Proteom. 2019 Oct;1867(10):890-908. doi: 10.1016/j.bbapap.2019.03.001. Epub 2019 Mar 7.

Comparison of Efficacy of Deep Brain Stimulation of Different Targets in Parkinson's Disease: A Network Meta-Analysis

Mao Z, Ling Z, Pan L, Xu X, Cui Z, Liang S, Yu X.

Front Aging Neurosci. 2019 Feb 22;11:23. doi: 10.3389/fnagi.2019.00023. eCollection 2019.

Case of risperidone-induced tardive parkinsonism

Bolu A, Garip B, Öznur T, Uzun Ö.

Psychiatry Clin Neurosci. 2019 May;73(5):285-286. doi: 10.1111/pcn.12837. Epub 2019 Mar 25.

Mucuna Pruriens Combined with Carbidopa in Parkinson's Disease: A Case Report

Radder DLM, Tiel Groenestege AT, Boers I, Muilwijk EW, Bloem BR.

J Parkinsons Dis. 2019;9(2):437-439. doi: 10.3233/JPD-181500.

The related factors of sleep benefit in Parkinson's disease: A systematic review and meta-analysis

Rui Z, Qingling C, Xinyue Z, Xin Z, Weihong L.

PLoS One. 2019 Mar 11;14(3):e0212951. doi: 10.1371/journal.pone.0212951. eCollection 2019.

Improvement of Deep Brain Stimulation in Dyskinesia in Parkinson's Disease: A Meta-Analysis

Liu Y, Li F, Luo H, He Q, Chen L, Cheng Y, Zhang W, Xie Z.

Front Neurol. 2019 Feb 25;10:151. doi: 10.3389/fneur.2019.00151. eCollection 2019.

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells

Garretti F, Agalliu D, Lindestam Arlehamn CS, Sette A, Sulzer D.

Front Immunol. 2019 Feb 25;10:303. doi: 10.3389/fimmu.2019.00303. eCollection 2019.

Recent advancements in lateral trunk flexion in Parkinson disease

Kataoka H, Sugie K.

Neurol Clin Pract. 2019 Feb;9(1):74-82. doi: 10.1212/CPJ.0000000000000574.

Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease

Martinez A, Lopez N, Gonzalez C, Hetz C.

Biol Cell. 2019 Jun;111(6):161-168. doi: 10.1111/boc.201800068. Epub 2019 Mar 25.

Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans

Silzer T, Barber R, Sun J, Pathak G, Johnson L, O'Bryant S, Phillips N.

PLoS One. 2019 Mar 12;14(3):e0213527. doi: 10.1371/journal.pone.0213527. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias